Merck Study | Understanding Multiple Sclerosis

Only 20% of the population distinguishes between multiple sclerosis and ALS Merck has presented a study on Spanish society’s perception and knowledge of multiple sclerosis, with technical support from GAD3. The aim of this research is to analyse the level of information, beliefs and impact that the population attributes to this disease. The results reveal…

Details

Mediaset Study I COVID

Five years have passed since the COVID-19 pandemic began, and we are examining some of its key aspects. Mediaset, in collaboration with GAD3, has published a study analysing the most relevant insights and perspectives regarding the COVID-19 pandemic and its management. This study gathers the various opinions of Spaniards on the most significant and socially…

Details

ECO Foundation Study | World Cancer Day

4 February marks World Cancer Day. On the occasion of this day, the ECO Foundation will present and analyse the data from a survey carried out by GAD3 as part of the Cancer Now project in the Congress of Deputies. A study which reveals that this disease is the main health concern for Spanish society.…

Details

II Study of Spanish society’s perception of flu vaccination

Sara Morais presented the second edition of the flu vaccination perception study, conducted by GAD3, with the support of CSL Seqirus. The press conference was attended by Javier Castrodeza, Head of the Preventive Medicine Department of the Hospital Clínico Universitario de Valladolid, among other professionals from the sector. According to the study, in which 2,219…

Details

The role of pharmacy in the future

Narciso Michavila took part in the press conference organised by the General Council of Pharmaceutical Associations to present the main conclusions of the study carried out by GAD3, “The role of pharmacy in the future”. The event was attended by Jesús Aguila, president of the General Council of Pharmaceutical Associations, and Narciso Michavila. Among the…

Details